Stergiopoulos, S., Karabinis, A., Mandragos, K., Komnos, A., Soukup, J., Speelberg, B., & Kirkham, A. (2004). The safety of remifentanil administered for up to 5 days in ICU patients with neurotrauma. BioMed Central.
Styl ChicagoStergiopoulos, S., A. Karabinis, K. Mandragos, A. Komnos, J. Soukup, B. Speelberg, a A. Kirkham. The Safety of Remifentanil Administered for Up to 5 Days in ICU Patients With Neurotrauma. BioMed Central, 2004.
Citace podle MLAStergiopoulos, S., et al. The Safety of Remifentanil Administered for Up to 5 Days in ICU Patients With Neurotrauma. BioMed Central, 2004.
Upozornění: Tyto citace jsou generovány automaticky. Nemusí být zcela správně podle citačních pravidel..